BCAB Competitors & Alternatives
Compare Bioatla Inc with similar stocks in the same industry
Biotechnology
BCAB
Main Stock$1.74
Tradestie Score
39
Market Cap
$39.57M
Revenue Growth
0.3%
Analyst Upside
+476.4%
Top Competitors
220 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
NVCT
Nuvectis Pharma, Inc. Common Stock
|
$21.08
|
$154.27M | - | 43 | Compare |
|
CCCC
C4 Therapeutics, Inc.
|
$3.00
|
$153.02M | - | 50 | Compare |
|
CLYM
Climb Bio, Inc. Common Stock
|
$11.74
|
$133.50M | - | 32 | Compare |
|
SRZN
Surrozen, Inc. Common
|
$32.64
|
$117.07M | - | 34 | Compare |
|
STTK
Shattuck Labs, Inc. Common Stock
|
$4.85
|
$114.01M | - | 58 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$28.61
|
$110.20M | - | 41 | Compare |
|
OVID
Ovid Therapeutics Inc. Common Stock
|
$2.80
|
$97.42M | - | 39 | Compare |
|
ALXO
ALX Oncology Holdings Inc. Common Stock
|
$1.11
|
$96.93M | - | 44 | Compare |
|
ENTX
Entera Bio Ltd. Ordinary Shares
|
$3.24
|
$84.52M | - | 42 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$8.35
|
$67.94M | - | 54 | Compare |
More BCAB Analysis
Data updated: Nov 11, 2026 | Industry: Biotechnology (SIC 2836)
220 stocks in this industry